Steven R. Bergmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Steven R. Bergmann has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
P Herrero
5 shared publicationsJ J Hartman
3 shared publicationsJ Markham
3 shared publicationsK.T Hickey
College of Physicians and Surgeons-Columbia University Medical Center, USA
3 shared publicationsC J Weinheimer
2 shared publications- Carolyn J. Anderson
Department of Chemistry, University of Missouri, Columbia, Missouri
2 shared publications
Latest Publications
- 1 August 2004
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 11 (4) , S11
Comparison of exercise tolerance and chest pain during exercise stress testing in three different ethnic groups
- 1 August 2004
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 11 (4) , S11
Comparison of exercise tolerance and chest pain during exercise stress testing in three different ethnic groups
- 1 July 2004
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 11 (4) , S30
The reverse flow-metabolism mismatch pattern seen in cardiac PET viability scans is unrelated to underlying degree of coronary stenosis
- 1 July 2004
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 11 (4) , S30
The reverse flow-metabolism mismatch pattern seen in cardiac PET viability scans is unrelated to underlying degree of coronary stenosis
- 1 July 2004
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 11 (4) , S29-S30
The reverse flow-metabolism mismatch pattern seen in myocardial viability PET scans reflects altered substrate utilization
- 1 July 2004
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 11 (4) , S29-S30
The reverse flow-metabolism mismatch pattern seen in myocardial viability PET scans reflects altered substrate utilization
- 1 July 2004
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 11 (4) , S29
The influence of myocardial perfusion imaging and chest pain on treatment of patients with ischemic heart failure
- 1 July 2004
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 11 (4) , S29
The influence of myocardial perfusion imaging and chest pain on treatment of patients with ischemic heart failure
- 1 June 2003
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (12) , 1410-1414
Value of definitive diagnostic testing in the evaluation of patients presenting to the emergency department with chest pain
- 1 June 2003
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (12) , 1410-1414
Value of definitive diagnostic testing in the evaluation of patients presenting to the emergency department with chest pain
- 1 November 2001
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 24 (6) , 657-674
Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy
Inherited defects in myocardial long‐chain fatty acid metabolism are increasingly recognized as a cause of cardiomyopathy and sudden death in children. To evaluate whether the phenotypic expression o...
- 1 November 2001
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 24 (6) , 657-674
Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy
Inherited defects in myocardial long‐chain fatty acid metabolism are increasingly recognized as a cause of cardiomyopathy and sudden death in children. To evaluate whether the phenotypic expression o...
- 1 May 2001
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (9) , 1096-1099
Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction
- 1 May 2001
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (9) , 1096-1099
Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction
- 1 May 2001
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 8 (3) , 325-332
Failure of right precordial electrocardiography during stress testing to identify coronary artery disease
- 1 May 2001
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 8 (3) , 325-332
Failure of right precordial electrocardiography during stress testing to identify coronary artery disease
- 1 February 2001
- Vol. 42 (2) , 201-8
Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction.
Quantification of myocardial perfusion with 82Rb has been difficult to achieve because of the low signal-to-noise ratio of the dynamic data curves. This study evaluated the accuracy of flow estimates after the application of a novel multidimensional wavelet-based noise-reduction protocol. Myocardial perfusion was estimated using 82Rb and a two-compartment model from dynamic PET scans on 11 healthy volunteers at rest and after hyperemic stress with dipyridamole. Midventricular planes were divided into eight regions of interest, and a wavelet transform protocol was applied to images and time-activity curves. Flow estimates without and with the wavelet approach were compared with those obtained using H2(15)O. Over a wide flow range (0.45-2.75 mL/g/min), flow achieved with the wavelet approach correlated extremely closely with values obtained with H2(15)O (y = 1.03 x -0.12; n = 23 studies, r = 0.94, P < 0.001). If the wavelet noise-reduction technique was not used, the correlation was less strong (y = 1.11 x + 0.24; n = 23 studies, r = 0.79, P < 0.001). In addition, the wavelet approach reduced the regional variation from 75% to 12% and from 62% to 11% (P < 0.001 for each comparison) for resting and stress studies, respectively. The use of a wavelet protocol allows near-optimal noise reduction, markedly enhances the physiologic flow signal within the PET images, and enables accurate measurement of myocardial perfusion with 82Rb in human subjects over a wide range of flows.
- 1 February 2001
- Vol. 42 (2) , 201-8
Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction.
Quantification of myocardial perfusion with 82Rb has been difficult to achieve because of the low signal-to-noise ratio of the dynamic data curves. This study evaluated the accuracy of flow estimates after the application of a novel multidimensional wavelet-based noise-reduction protocol. Myocardial perfusion was estimated using 82Rb and a two-compartment model from dynamic PET scans on 11 healthy volunteers at rest and after hyperemic stress with dipyridamole. Midventricular planes were divided into eight regions of interest, and a wavelet transform protocol was applied to images and time-activity curves. Flow estimates without and with the wavelet approach were compared with those obtained using H2(15)O. Over a wide flow range (0.45-2.75 mL/g/min), flow achieved with the wavelet approach correlated extremely closely with values obtained with H2(15)O (y = 1.03 x -0.12; n = 23 studies, r = 0.94, P < 0.001). If the wavelet noise-reduction technique was not used, the correlation was less strong (y = 1.11 x + 0.24; n = 23 studies, r = 0.79, P < 0.001). In addition, the wavelet approach reduced the regional variation from 75% to 12% and from 62% to 11% (P < 0.001 for each comparison) for resting and stress studies, respectively. The use of a wavelet protocol allows near-optimal noise reduction, markedly enhances the physiologic flow signal within the PET images, and enables accurate measurement of myocardial perfusion with 82Rb in human subjects over a wide range of flows.
- 1 January 2001
- Vol. 42 (1) , 63-70
Measurement of myocardial blood flow with PET using 1-11C-acetate.
11C-acetate has been used extensively for the noninvasive assessment of myocardial oxygen consumption and viability with PET. The use of early uptake of acetate by the heart to measure myocardial perfusion has been proposed. This study evaluated the application of 11C-acetate for absolute measurement of myocardial blood flow using a simple compartmental model that does not require blood sampling. Eight healthy volunteers and 13 subjects with concentric left ventricular hypertrophy were studied under resting conditions with both 11Cacetate and 15O-water. Myocardial blood flow with 11C-acetate was obtained by fitting the first 3 min of the blood and tissue tracer activity curves to a two-compartment model. Flows obtained were compared with a validated approach using 15O-water. In healthy volunteers, regional myocardial perfusion at rest estimated with 11C-acetate was comparable with values obtained with 15O-water (1.06 +/- 0.25 and 0.96 +/- 0.12 mL/g/min, respectively). Perfusion in subjects with left ventricular hypertrophy was also comparable if the recovery coefficient (FMM) used was corrected for ventricular mass. If a fixed FMM was used, flow was greatly overestimated. FMM could be estimated from left ventricular mass (FMM = 0.46 + 0.002 x mass, r = 0.86, P < 0.0001). The results of this study suggest that 11C-acetate can be applied to quantitatively estimate myocardial perfusion under resting conditions using a two-compartment model without the need for blood sampling, provided that an appropriate FMM is chosen. This approach should increase the usefulness of this tracer and obviate administration of a separate tracer to independently measure perfusion.
- 1 January 2001
- Vol. 42 (1) , 63-70
Measurement of myocardial blood flow with PET using 1-11C-acetate.
11C-acetate has been used extensively for the noninvasive assessment of myocardial oxygen consumption and viability with PET. The use of early uptake of acetate by the heart to measure myocardial perfusion has been proposed. This study evaluated the application of 11C-acetate for absolute measurement of myocardial blood flow using a simple compartmental model that does not require blood sampling. Eight healthy volunteers and 13 subjects with concentric left ventricular hypertrophy were studied under resting conditions with both 11Cacetate and 15O-water. Myocardial blood flow with 11C-acetate was obtained by fitting the first 3 min of the blood and tissue tracer activity curves to a two-compartment model. Flows obtained were compared with a validated approach using 15O-water. In healthy volunteers, regional myocardial perfusion at rest estimated with 11C-acetate was comparable with values obtained with 15O-water (1.06 +/- 0.25 and 0.96 +/- 0.12 mL/g/min, respectively). Perfusion in subjects with left ventricular hypertrophy was also comparable if the recovery coefficient (FMM) used was corrected for ventricular mass. If a fixed FMM was used, flow was greatly overestimated. FMM could be estimated from left ventricular mass (FMM = 0.46 + 0.002 x mass, r = 0.86, P < 0.0001). The results of this study suggest that 11C-acetate can be applied to quantitatively estimate myocardial perfusion under resting conditions using a two-compartment model without the need for blood sampling, provided that an appropriate FMM is chosen. This approach should increase the usefulness of this tracer and obviate administration of a separate tracer to independently measure perfusion.